Annual CFO
-$36.10 M
+$1.44 M+3.85%
December 31, 2023
Summary
- As of February 7, 2025, CRBP annual cash flow from operations is -$36.10 million, with the most recent change of +$1.44 million (+3.85%) on December 31, 2023.
- During the last 3 years, CRBP annual CFO has risen by +$63.59 million (+63.79%).
- CRBP annual CFO is now -9744.70% below its all-time high of -$366.70 thousand, reached on December 31, 2013.
Performance
CRBP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.94 M
-$5.00 M-55.91%
September 30, 2024
Summary
- As of February 7, 2025, CRBP quarterly cash flow from operations is -$13.94 million, with the most recent change of -$5.00 million (-55.91%) on September 30, 2024.
- Over the past year, CRBP quarterly CFO has dropped by -$7.93 million (-132.04%).
- CRBP quarterly CFO is now -235.12% below its all-time high of $10.32 million, reached on March 31, 2019.
Performance
CRBP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$36.86 M
-$6.77 M-22.48%
September 30, 2024
Summary
- As of February 7, 2025, CRBP TTM cash flow from operations is -$36.86 million, with the most recent change of -$6.77 million (-22.48%) on September 30, 2024.
- Over the past year, CRBP TTM CFO has dropped by -$760.00 thousand (-2.11%).
- CRBP TTM CFO is now -26228.93% below its all-time high of -$140.00 thousand, reached on March 31, 2014.
Performance
CRBP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CRBP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -132.0% | -2.1% |
| 3 y3 years | +63.8% | -87.0% | +1.8% |
| 5 y5 years | -20.1% | -87.0% | +1.8% |
CRBP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.1% | -132.0% | +7.8% | -27.3% | +23.5% |
| 5 y | 5-year | at high | +63.8% | -1726.8% | +49.5% | -27.3% | +64.6% |
| alltime | all time | -9744.7% | +63.8% | -235.1% | +49.5% | <-9999.0% | +64.6% |
Corbus Pharmaceuticals Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.94 M(+55.9%) | -$36.86 M(+22.5%) |
| Jun 2024 | - | -$8.94 M(+12.2%) | -$30.09 M(+3.9%) |
| Mar 2024 | - | -$7.97 M(+32.6%) | -$28.95 M(-19.8%) |
| Dec 2023 | -$36.10 M(-3.8%) | -$6.01 M(-16.3%) | -$36.10 M(-3.9%) |
| Sep 2023 | - | -$7.18 M(-8.0%) | -$37.55 M(-0.2%) |
| Jun 2023 | - | -$7.80 M(-48.4%) | -$37.62 M(-10.5%) |
| Mar 2023 | - | -$15.12 M(+102.7%) | -$42.04 M(+12.0%) |
| Dec 2022 | -$37.54 M(-22.1%) | -$7.46 M(+2.9%) | -$37.54 M(-5.6%) |
| Sep 2022 | - | -$7.25 M(-40.8%) | -$39.79 M(+25.6%) |
| Jun 2022 | - | -$12.23 M(+15.2%) | -$31.69 M(-14.3%) |
| Mar 2022 | - | -$10.62 M(+9.4%) | -$36.99 M(-23.2%) |
| Dec 2021 | -$48.18 M(-51.7%) | -$9.70 M(-1232.2%) | -$48.18 M(-15.0%) |
| Sep 2021 | - | $857.00 K(-104.9%) | -$56.71 M(-33.1%) |
| Jun 2021 | - | -$17.53 M(-19.6%) | -$84.82 M(-9.7%) |
| Mar 2021 | - | -$21.81 M(+19.7%) | -$93.89 M(-5.8%) |
| Dec 2020 | -$99.69 M(+118.0%) | -$18.22 M(-33.1%) | -$99.69 M(-4.2%) |
| Sep 2020 | - | -$27.25 M(+2.4%) | -$104.02 M(+10.8%) |
| Jun 2020 | - | -$26.61 M(-3.6%) | -$93.86 M(+12.2%) |
| Mar 2020 | - | -$27.60 M(+22.3%) | -$83.64 M(+82.9%) |
| Dec 2019 | -$45.72 M | -$22.56 M(+32.0%) | -$45.72 M(+22.8%) |
| Sep 2019 | - | -$17.09 M(+4.2%) | -$37.22 M(+28.4%) |
| Jun 2019 | - | -$16.39 M(-258.8%) | -$28.98 M(+59.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $10.32 M(-173.4%) | -$18.15 M(-39.6%) |
| Dec 2018 | -$30.07 M(+8.2%) | -$14.06 M(+59.0%) | -$30.07 M(+19.7%) |
| Sep 2018 | - | -$8.85 M(+59.2%) | -$25.12 M(+11.1%) |
| Jun 2018 | - | -$5.56 M(+247.4%) | -$22.60 M(-0.7%) |
| Mar 2018 | - | -$1.60 M(-82.5%) | -$22.76 M(-18.1%) |
| Dec 2017 | -$27.80 M(+104.8%) | -$9.11 M(+43.9%) | -$27.80 M(+15.0%) |
| Sep 2017 | - | -$6.33 M(+10.8%) | -$24.16 M(+15.7%) |
| Jun 2017 | - | -$5.71 M(-13.9%) | -$20.88 M(+18.0%) |
| Mar 2017 | - | -$6.64 M(+21.1%) | -$17.69 M(+30.4%) |
| Dec 2016 | -$13.57 M(+193.4%) | -$5.48 M(+79.6%) | -$13.57 M(+51.2%) |
| Sep 2016 | - | -$3.05 M(+20.8%) | -$8.97 M(+6.8%) |
| Jun 2016 | - | -$2.53 M(+0.5%) | -$8.41 M(+43.5%) |
| Mar 2016 | - | -$2.52 M(+185.5%) | -$5.86 M(+26.7%) |
| Dec 2015 | -$4.62 M(+95.9%) | -$881.00 K(-64.5%) | -$4.62 M(-8.7%) |
| Sep 2015 | - | -$2.48 M(<-9900.0%) | -$5.07 M(+60.3%) |
| Jun 2015 | - | $19.50 K(-101.5%) | -$3.16 M(-9.7%) |
| Mar 2015 | - | -$1.28 M(-3.1%) | -$3.50 M(+48.3%) |
| Dec 2014 | -$2.36 M(+543.9%) | -$1.32 M(+128.5%) | -$2.36 M(+127.0%) |
| Sep 2014 | - | -$578.30 K(+79.8%) | -$1.04 M(+125.3%) |
| Jun 2014 | - | -$321.70 K(+129.8%) | -$461.70 K(+229.8%) |
| Mar 2014 | - | -$140.00 K | -$140.00 K |
| Dec 2013 | -$366.70 K | - | - |
FAQ
- What is Corbus Pharmaceuticals Holdings annual cash flow from operations?
- What is the all time high annual CFO for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual CFO year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly CFO year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM CFO year-on-year change?
What is Corbus Pharmaceuticals Holdings annual cash flow from operations?
The current annual CFO of CRBP is -$36.10 M
What is the all time high annual CFO for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual cash flow from operations is -$366.70 K
What is Corbus Pharmaceuticals Holdings annual CFO year-on-year change?
Over the past year, CRBP annual cash flow from operations has changed by +$1.44 M (+3.85%)
What is Corbus Pharmaceuticals Holdings quarterly cash flow from operations?
The current quarterly CFO of CRBP is -$13.94 M
What is the all time high quarterly CFO for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly cash flow from operations is $10.32 M
What is Corbus Pharmaceuticals Holdings quarterly CFO year-on-year change?
Over the past year, CRBP quarterly cash flow from operations has changed by -$7.93 M (-132.04%)
What is Corbus Pharmaceuticals Holdings TTM cash flow from operations?
The current TTM CFO of CRBP is -$36.86 M
What is the all time high TTM CFO for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM cash flow from operations is -$140.00 K
What is Corbus Pharmaceuticals Holdings TTM CFO year-on-year change?
Over the past year, CRBP TTM cash flow from operations has changed by -$760.00 K (-2.11%)